Arcturus Therapeutics Holdings, Inc. (ARCT)
10.81
-0.31
(-2.79%)
USD |
NASDAQ |
Oct 15, 10:53
Arcturus Therapeutics Holdings Total Long Term Debt (Quarterly) : 18.97M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.97M |
| March 31, 2026 | 19.68M |
| December 31, 2025 | 20.78M |
| September 30, 2025 | 21.86M |
| June 30, 2025 | 22.93M |
| March 31, 2025 | 38.99M |
| December 31, 2024 | 25.00M |
| September 30, 2024 | 25.99M |
| June 30, 2024 | 26.96M |
| March 31, 2024 | 27.65M |
| December 31, 2023 | 25.91M |
| September 30, 2023 | 47.02M |
| June 30, 2023 | 28.11M |
| March 31, 2023 | 29.19M |
| December 31, 2022 | 90.87M |
| September 30, 2022 | 90.96M |
| June 30, 2022 | 94.98M |
| March 31, 2022 | 67.55M |
| December 31, 2021 | 67.61M |
| September 30, 2021 | 65.76M |
| June 30, 2021 | 66.67M |
| March 31, 2021 | 66.98M |
| December 31, 2020 | 19.12M |
| September 30, 2020 | 19.23M |
| June 30, 2020 | 19.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.66M |
| December 31, 2019 | 19.84M |
| September 30, 2019 | 15.08M |
| June 30, 2019 | 15.26M |
| March 31, 2019 | 15.43M |
| December 31, 2018 | 9.911M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Emergent BioSolutions, Inc. | 586.70M |
| Exelixis, Inc. | 165.93M |
| Ionis Pharmaceuticals, Inc. | 2.189B |
| United Therapeutics Corp. | 0.00 |